Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 Trial. Bartlett EK, Barker CA. Ann Surg Oncol 2026 Jun 4. doi: 10.1245/s10434-026-19938.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bartlett EK, Barker CA. Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 Trial. Ann Surg Oncol 2026 Jun 4. doi: 10.1245/s10434-026-19938.
PMID: 42240785